Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements clinical trial longevity nad+ nootropics
Approach 3, the human outcome, in palette D, a bold color field. Close-up of an older adult's bare upper arm, seen from a slightly high three-quarter angle, with a blood pressure cuff wrapped snugly above the elbow. The cuff is matte graphite grey with a coiled rubber tube trailing out of frame. The arm shows real skin texture, freckles and fine creases, and the face is out of frame. The backdrop is a saturated, flat tomato-red wall. A small electric green LED glows on the cuff's digital monitor at the edge of the frame, with its display blurred and unreadable. Soft, even studio light comes from the left, with gentle shadows and no blue cast. Shallow depth of field keeps the cuff edge and skin pores sharp. The mood is calm, clinical and quietly hopeful.
Supplements

NMN lan Tekanan Darah: Ringkesan 10 Uji Gabungan, Penurunan Terbanyak ing Umur >60

Nova Chen · · 4 min read
#meta analysis #healthy aging #nmn #nad+ #cardiovascular health #blood pressure

Nicotinamide mononucleotide (NMN) lan Tekanan Darah: Apa Sing Bener?

Nicotinamide mononucleotide (NMN) saiki dadi salah siji suplemen anti‑penuaan sing paling ramai dibahas. Akeh sing nyambungake NMN karo peningkatan tingkat NAD⁺, energi sel, lan penuaan sing luwih sehat. Review sistematis lan meta‑analisis anyar ing Nutrients (Zhang et al., 2026) njaluk jawaban praktis: apa NMN bisa ngowahi tekanan darah wong sing wis nduwèni tekanan tinggi? Jawabané mung “bisa wae”, lan efek paling gedhé katon ing kelompok umur 60 taun utawa luwih.

Apa Sing Ditliti Peneliti?

Tim riset nggolèki PubMed/MEDLINE, Scopus, Web of Science lan EBSCO saka wiwitan nganti 13 Desember 2025 kanggo nemokake uji klinis terkontrol acak (RCT) sing nggunakake suplementasi NMN lan nyathet tekanan darah istirahat. Saka 10 RCT (kalebu 11 lengan intervensi) sing melu total 349 peserta, data kasebut digabung lan dibandhingake karo plasebo.

Asil diproses nganggo model efek umum ing R, banjur dilakokaké analisis subkelompok adhedhasar umur, indeks massa awak (BMI) awal, lokasi geografis, suwéné intervensi, dosis NMN, lan tekanan darah awal.

Angka‑Angka Pokok

  • Tekanan diastolik (DBP): NMN terkait karo penurunan sing statistik signifikan nanging cilik, ‑2,15 mmHg (95 % CI: ‑3,68 nganti ‑0,61) dibandhingake karo plasebo.
  • Tekanan sistolik (SBP): Penurunan sakabèhé ora signifikan sacara statistik.
  • Umur ≥ 60 taun: Ing analisis subkelompok umur, SBP mudhun ‑3,94 mmHg (95 % CI: ‑7,06 nganti ‑0,82).

Penurunan ing kelompok umur >60 iki paling nyolok, nanging kudu diwaca kanthi jeli. Interval kapercayané amba, saka mudhun 7 mmHg nganti kurang saka 1 mmHg, sing nuduhaké kemungkinan efek klinis menarik nganti ora ketok babar pisan.

Nglacak Penurunan 2‑4 mmHg ing Konteks

Penurunan kira‑kira 2 mmHg ing tekanan diastolik memang signifikan sacara statistik, nanging cilik yen dipandang saka praktik saben dina. Obat antihipertensi standar umume nurunake tekanan sistolik luwih gedhé, lan owah‑owahan gaya urip kaya ngurangi natrium, ngurangi bobot, lan olahraga rutin uga bisa nyebabake penurunan sing padha utawa malah luwih gedhé.

Model populasi nuduhaké yèn penurunan cilik rata‑rata bisa duwé dampak positif yen diaplikasikan ing populasi gedhé suwé taun‑taun, nanging iki ora padha karo bukti yèn siji wong sing njupuk NMN bakal entuk manfaat kesehatan sing penting.

Penulis ngandharake temuan iki minangka "prabayak lan sugestif." NMN ora kabuktèn dadi pengganti obat tekanan darah, lan ora ana bukti ing analisis iki sing nyaranake ngurangi utawa mandhegake pengobatan sing wis dipreskripsikaké.

Napa Sinyal Umur >60 Menarik Nanging Rapuh

Ana logika biologis sing masuk akal. Tingkat NAD⁺ cenderung mudhun karo umur, lan NAD⁺ melu fungsi vaskular, kesehatan mitokondria, lan respon seluler marang stres. Yen NMN nambah ketersediaan NAD⁺, wong tuwa sing nduwèni tingkat NAD⁺ luwih murah lan arteri sing luwih kaku bisa luwih responsif. Iki hipotesis sing logis, nanging analisis iki ora bisa mbuktekaké mekanisme kasebut.

Sawetara peringatan penting:

  • Sampel total cilik. Karo 349 peserta sing nyebar ing 10 uji, saben subkelompok dadi luwih cilik lan luwih rawan kebetulan.
  • Analisis subkelompok. Efek SBP sakabèhé ora signifikan. Nemokake asil signifikan ing siji bagéan data kudu dianggep hipotesis kanggo diteliti luwih lanjut, dudu kesimpulan final.
  • Model efek umum. Pendekatan iki nganggep kabeh uji ngukur hiji efek sejati sing tunggal. Yen studi béda ing dosis, lamanya, populasi, lan formulasi (kaya sing asring kedadéan), model efek acak bakal maringi interval sing luwih amba lan asil sing luwih konservatif. Mula, panemu iki bisa uga optimis.
  • Heterogenitas intervensi. Saben uji nganggo rejimen NMN sing béda‑bèda, dadi angka gabungan mung nyathet rata‑rata sing nyembunyikan variasi antarane studi.

Dosis lan Durasi

Abstrak nyatakake yèn analisis subkelompok wis dilakokaké adhedhasar dosis NMN lan lamanya intervensi, nanging ora nyebutake dosis utawa wektu persis sing dipigunakaké. Sumber asli nuduhaké dosis lan durasi béda‑bèda antarane uji. Kanggo rincian luwih jero, paca artikel lengkapé tinimbang mung ngandelake ringkesan iki.

Sapa Sing Pantes Nggunakake Informasi Iki?

Analisis iki fokus ing wong diwasa sing nduwèni tekanan darah tinggi, mula asilé paling relevan kanggo:

  • Wong tuwa, utamane sing ≥ 60 taun, sing lagi nliti NMN kanggo penuaan sehat.
  • Wong sing tekanan darahé rada mundhak lan butuh tambahan saka gaya urip, kanthi pangawasan medis.
  • Peneliti sing ngrancang uji gedhé marang prekursor NAD⁺.

Informasi iki ora pati relevan kanggo wong sing tekanan darahé normal, lan ora dadi bukti kanggo ngatasi hipertensi mung nganggo NMN.

Apa Sing Isih Durung Diketahui?

Penulis nyuwun luwih akeh RCT jangka panjang, skala gedhé, lan kualitas dhuwur. Pitakon sing isih terbuka antara liya: apa efek iki tetep sawise suplemen jangka panjang, apa NMN nyuda kejadian kardiovaskular, kepriyé NMN dibandhingake karo prekursor NAD⁺ liyané kaya nicotinamide riboside, lan sapa sing paling mungkin merespon positif. Pengukuran tekanan darah ing omah utawa ambulatory 24 jam ing uji mendatang uga bakal mbantu misahake efek nyata saka fluktuasi kunjungan klinik.

Kesimpulan Praktis

  • Efek cilik. Penurunan ‑2,15 mmHg kanggo tekanan diastolik signifikan sacara statistik nanging mung sithik.
  • Tekanan sistolik ora berubah signifikan sacara keseluruhan. Penurunan ‑3,94 mmHg mung katon ing subkelompok umur ≥ 60.
  • Bukti isih awal. Sepuluh uji lan 349 wong iku dhasar sing winates, lan panemu iki kudu dianggap preliminer.
  • NMN dudu obat tekanan darah. Aja diganti utawa dikurangi obat sing dipreskripsikaké merga saka analisis iki.
  • Rembugan dhisik karo dokter. Iki penting menawa sampeyan nggunakake antihipertensi, duwe riwayat ginjal utawa jantung, utawa lagi hamil lan nyusoni. Awasi tekanan darah ing omah menawa nambah suplemen anyar.
  • Pondasi dhasar tetep menang. Diet seimbang, aktivitas rutin, turu sing cukup, ngatur bobot, lan ngurangi natrium nduwèni bukti luwih kuat kanggo ngendhaleni tekanan darah.

Ringkesan Pungkasan

Meta‑analisis iki nambahaké titik data sing migunani, sanajan isih winates, kanggo diskusi NMN. Iku nuduhaké manfaat cilik kanggo tekanan diastolik lan kamungkinan manfaat sistolik ing wong tuwa, nanging sampel cilik, model optimis, lan temuan utama asal saka subkelompok. Saiki, NMN katon dadi kandidat menarik sing pantes diuji luwih jero, dudu piranti sing wis teruji kanggo ngatur tekanan darah.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach 4, conceptual metaphor, in palette D, bold color field. A single AA-style cylindrical battery, shown as a real physical object with a matte metal casing, stands upright at the center of a saturated tomato-red seamless paper backdrop. Its top half is bright and glossy, while the lower half is scuffed and dull. A thin, crisp line of electric green liquid light fills the clear gauge window along its side, stopping about three-quarters of the way up. Three smaller, identical dead batteries lie tipped over in the foreground, slightly out of focus, to suggest the rival compounds. The camera sits at a low three-quarter angle with a shallow depth of field. A hard, warm key light from the upper left casts a sharp, long shadow across the red surface. The mood is punchy and skeptical: one cell charged, the others spent.
supplements

NMN vs NR vs NADH: Siji Nambah Ketahanan, Ora Ana Sing Bisa Ngatasi Kelelahan

BY NOVA CHEN ·

Analisis jaringan meta anyar sing nyakup 27 studi lan 1.599 wong diwasa mbandhingaké NMN, NR, NADH, lan nikotinamida. Hasilé ora cocog karo janji pemasaran suplemen. NMN nuduhaké peningkatan daya tahan sing gumantung dosis (SMD ≈ 1,02 ing dosis dhuwur). NADH luwih apik kanggo kognisi, nanging mung ing kelompok sing duwe gangguan kognitif lan asilé sensitif marang sawetara studi. Kejutané, ora ana prekursor sing sacara signifikan ningkataké rasa lelah utawa kualitas turu. Artikel iki njelasaké cara peringkat diévaluasi, watesane, lan sapa sing kudu utawa ora kudu nyoba suplemen iki.
**Approach:** Macro science. **Palette:** D, bold color field. Extreme close-up of a small mound of white taurine crystals, needle-like and prismatic, shot at a 35-degree angle with a macro lens and shallow depth of field. The front crystals are razor sharp, with faceted edges that catch light and show tiny internal fractures. The mound sits on a glossy, saturated tomato-red acrylic surface that reflects a soft, blurred mirror image of the crystals. A large softbox from the upper left gives crisp highlights and warm red bounce in the shadows. A single crystal near the focal point carries a faint electric green (#00e676) refraction glint. The background melts into an out-of-focus gradient of deep red and orange. The mood is precise, energetic and confident, with a clean scientific feel. No text, no labels, no containers.
supplements

Taurine 1,5–3 g Spot Manis: Apa sing Ditemokake saka 34 Uji babagan Gula lan Tekanan Darah

BY NOVA CHEN ·

Taurine misuwur amarga hype anti‑penuaan, nanging meta‑analisis 34 uji acak paling anyar nuduhaké pratanda kesehatan saben dina. Suplemen iki kagandheng karo penurunan glukosa puasa, HbA1c, trigliserida, kolesterol, tekanan darah, lan peradangan. Manfaat paling kentara nalika dosis 1,5–3 g saben dina, lan durasi efek uga béda: glukosa lan lemak luwih apik sawisé 8 minggu utawa luwih, dene tekanan darah lan peradangan luwih cepet katon ing trial sing luwih cekak. Efek iki modest lan trial‑e béda‑bèda, mula penting kanggo mangertèni sapa sing kudu ati‑ati.
**Approach: Human outcome. Palette: warm (B).** Extreme close-up, slightly high angle, of a woman's scalp parting in her 40s. Dense, glossy chestnut-brown hair is split by a fine comb. Short new hairs rise from the visible scalp skin, and a few strands catch the light. Faces and identity are out of frame. Low golden-hour window light enters from camera left and rim-lights the strands in honey and copper. Shadows stay warm brown, with no blue cast. The shallow depth of field blurs the background hair into soft amber bokeh. A thin steel trichoscopy probe tip sits at the edge of the frame, and a tiny electric green LED glints on its housing as the only accent. The mood is hopeful but scrutinizing, like a clinical check-up with a cautious eye.
supplements

NMN Nambah Kerapatan Rambut 57 % ing Uji Coba Manungsa—Ana Kecualian Gedhe

BY NOVA CHEN ·

NMN, suplemen sing nambah NAD+ lan dadi favorit para penggemar umur panjang, saiki kaping pisan dipriksani efeké marang pertumbuhan rambut manungsa. Ing uji pilot 12 minggu sing kalebu 15 wanita umur 40–50 taun, kerapatan rambut ing fase anagen mundhak saka 55,9 dadi 87,7 rambut/cm², déné diameter rambut nambah saka 75,3 dadi 78,8 µm. Para peserta uga nglaporake peningkatan kilau, elastisitas, lan volume rambut. Senadyan mangkono, ora ana grup plasebo, ukuran sampel cilik, lan penulis kagandheng karo pemasok NMN. Ing ngisor iki angka‑angka sing ditampilaké, apa sing ora ditampilaké, lan sapa sing kudu ngenteni.
Approach: conceptual metaphor. Palette: bold color field. A single oversized brass balance scale sits on a saturated tomato-red seamless backdrop, photographed at a low three-quarter angle. One pan holds a small, glowing ember-orange coal that is cooling and dimming to grey ash at its edges, standing for inflammation. The other pan holds a tightly coiled, freshly cut green plant sprout with a tiny electric green (#00e676) tip, standing for repair and growth. The scale tips slightly toward the ember, leaving the viewer unsure which side is better. Hard but clean studio key light from upper left casts a crisp, graphic shadow across the red surface. Brass shows real fingerprints and fine scratches, and the ash has a visible powdery texture. The mood is tense, thoughtful and questioning, with the whole image shot at shallow depth of field and the fulcrum in sharp focus. No text, no markings on the scale.
supplements

NMN Ngeredam Inflamasi Otot Sawisé Latihan—Nanging Regane Piro?

BY NOVA CHEN ·

NMN dipasarkan minangka penambah energi sel, nanging studi biopsi otot anyar nemokaké trade‑off sing ora dikira‑kira. Sawisé latihan kanthi restriksi aliran sangu sing nimbulaké kerusakan, 1.200 mg/ng dina NMN ngendhegaké sinyal inflamasi kaya TNF‑α lan IL‑10. Nanging, NMN uga nundha penanda perbaikan lan ngilangaké kenaikan mitokondria 171 % sing katon ing grup plasebo. Amarga panalitiyan iki mung nglumpukaké 11 wong enom sing ora terlatih, asilé durung bisa digeneralisasi, nanging nuduhaké yèn inflamasi sing luwih sithik sawisé latihan ora tansah luwih apik.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文